Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Reprod Toxicol. 2016 Jul 12;68:164–170. doi: 10.1016/j.reprotox.2016.07.010

Table 3. Differences in duration of breastfeeding associated with a doubling of the maternal serum-PFAS concentrations.

Model 1 a Model 2 a b c Model 3 a b d Model 4 b c e
Primiparous Multiparous Older cohort Younger cohort

Total breastfeeding (months)

Difference (95 % CI) Difference (95 % CI) Difference (95 % CI) Difference (95 % CI) p i Difference (95 % CI) Difference (95 % CI) p i
N=998 N=987 N=987 N=987
PFHx S -0.1 (-0.5; 0.2) -0.2 (-0.5; 0.2) -0.1 (-0.5; 0.3) -0.2 (-0.5; 0.2) 0.66 -0.2 (-0.7; 0.2) -0.1 (-0.6; 0.4) 0.75
PFOS -1.4 (-2.1; -0.6) -1.4 (-2.1; -0.6) -1.3 (-2.3; -0.3) -1.4 (-2.2; -0.7) 0.75 -2.2 (-3.5; -0.8) -1.0 (-1.9; -0.1) 0.14
PFOA -1.6 (-2.1; -1.0) -1.3 (-1.9; -0.7) -1.1 (-2.0; -0.1) -1.4 (-2.0; -0.8) 0.45 -1.8 (-3.0; -0.7) -1.1 (-1.7; -0.4) 0.21
PFNA -1.0 (-1.6; -0.3) -1.3 (-2.0; -0.7) -1.6 (-2.6; -0.6) -1.2 (-2.0; -0.5) 0.60 -1.8 (-2.8; -0.9) -0.7 (-1.5; -0.0) 0.07
PFDA -0.4 (-1.0; 0.2) -0.8 (-1.4; -0.3) -1.6 (-2.6; -0.7) -0.5 (-1.2; 0.1) 0.06 -1.2 (-2.0; -0.5) -0.3 (-1.1; 0.5) 0.10

Exclusivebreastfeeding (months)

Difference (95 % CI) Difference (95 % CI) Difference (95 % CI) Difference (95 % CI) p i Difference (95 % CI) Difference (95 % CI) p i

N=997 N=986 N=986 N=986
PFHx S -0.0 (-0.2; 0.1) -0.1 (-0.2; 0.1) -0.0 (-0.1; 0.1) -0.1 (-0.2; 0.0) 0.28 -0.1 (-0.2; 0.1) -0.0 (-0.2; 0.1) 0.91
PFOS -0.4 (-0.7; -0.1) -0.3 (-0.6; -0.1) -0.2 (-0.6; 0.1) -0.3 (-0.6; -0.1) 0.52 -0.4 (-0.8; 0.1) -0.3 (-0.6; -0.0) 0.88
PFOA -0.6 (-0.8; -0.4) -0.5 (-0.7; -0.3) -0.4 (-0.8; 0.0) -0.5 (-0.7; -0.3) 0.55 -0.6 (-0.9; -0.2) -0.4 (-0.7; -0.2) 0.52
PFNA -0.2 (-0.4; -0.0) -0.2 (-0.5; -0.0) -0.3 (-0.8; 0.1) -0.2 (-0.4; 0.0) 0.64 -0.2 (-0.5; 0.1) -0.3 (-0.6; 0.0) 0.76
PFDA -0.1 (-0.3; 0.1) -0.2 (-0.4; 0.0) -0.5 (-0.9; -0.1) -0.1 (-0.3; 0.1) 0.06 -0.1 (-0.3; 0.2) -0.3 (-0.6; -0.0) 0.27
a

Adjusted for cohort

b

Adjusted for maternal age, pre-pregnancy BMI, pregnancy alcohol intake, pregnancy smoking, education, and employment

c

Adjusted for parity

d

Interaction between parity and PFAS

e

Interaction between cohort and PFAS

i

p-value for interaction